BIOMAT Database Logo BIOMAT Database Logo

[Report of two cases of circulating anticoagulant directed against factor xi (author's transl)]. 1978

M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005172 Factor XI Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C. Coagulation Factor XI,Plasma Thromboplastin Antecedent,Blood Coagulation Factor XI,Factor 11,Factor Eleven,Antecedent, Plasma Thromboplastin,Factor XI, Coagulation,Thromboplastin Antecedent, Plasma
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
[Anti-factor XI circulating anticoagulant (author's transl)].
January 1981, Sangre,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
[Circulating anticoagulant directed against factor XI in a patient with biliary lithiasis].
March 1983, Revista clinica espanola,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
Circulating anticoagulant against factor XI in psoriasis.
January 1982, Journal of medicine,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
[Venous thrombosis, circulating anticoagulant and systemic lupus erythematosus. Two cases report in two identical HLA sisters (author's transl)].
April 1981, Annales de pediatrie,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
[Circulating anticoagulant against factor XII in a patient with autoimmune hemolitic anemia (author's transl)].
February 1982, Haematologica,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
A circulating anticoagulant directed against factor XIa in systemic lupus erythematosus.
October 1979, Arthritis and rheumatism,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII.
November 1972, Acta medica Scandinavica,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
[Venous thrombosis, circulating anticoagulant and systemic lupus erythematosus. Two cases reported in two identical HLA sisters (author's transl)].
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus.
January 1977, Acta haematologica,
M Vila, and J Monasterio, and P V Arangüena, and P Valentin, and M Pico, and J Triginer
A circulating anticoagulant against factor V.
January 1974, Acta medica Scandinavica,
Copied contents to your clipboard!